{
    "nct_id": "NCT03412773",
    "official_title": "RATIONALE-301: A Randomized, Open-label, Multicenter Phase 3 Study to Compare the Efficacy and Safety of BGB-A317 Versus Sorafenib as First-Line Treatment in Patients With Unresectable Hepatocellular Carcinoma",
    "inclusion_criteria": "1. Histologically confirmed diagnosis of HCC\n2. Barcelona Clinic Liver Cancer (BCLC) Stage B or C disease not amenable to or progressing after loco-regional therapy and not amenable to a curative treatment approach\n3. No prior systemic therapy for HCC (with the exception of HCC participants enrolled in the safety run-in substudy [Japan only])\n4. Measurable disease\n5. Child-Pugh score A\n6. Easter Cooperative Oncology Group (ECOG) Performance Status â‰¤ 1\n7. Adequate organ function\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC histology\n2. Tumor thrombus involving main trunk of portal vein or inferior vena cava\n3. Loco-regional therapy to the liver within 28 days before randomization\n4. Clinical evidence of portal hypertension with bleeding esophageal or gastric varices at Screening, or within 6 months before randomization\n5. Bleeding or thrombotic disorder or any prescribed anticoagulant requiring therapeutic international normalized ratio monitoring (eg, warfarin or similar agents) at Screening, or within 6 months before randomization/enrollment\n6. Presence at Screening of active immune deficiency or autoimmune disease and/or prior history of any immune deficiency or autoimmune disease that may relapse\n7. Participant with any condition requiring systemic treatment with either corticosteroids (> 10 mg daily of prednisone or equivalent) or other immunosuppressive medication within 14 days before randomization\n8. History of interstitial lung disease or non-infectious pneumonitis, unless induced by radiation therapy\n9. QT interval corrected for heart rate (QTc) (corrected by Fridericia's method) > 450 msec at Screening\n\nNOTE: Other protocol defined Inclusion/Exclusion criteria may apply.",
    "miscellaneous_criteria": "Key"
}